White Paper
Toward the end of 2010, the agenda for a new one-day meeting called “Mobile Pharma” promised to “answer the age old question ‘Is this finally the year of mobile’?” A few months later, Ernst & Young published a report that seemed to answer that question with a resounding “yes.”